Characterization of high-avidity cytomegalovirus-specific t cells with differential tetramer binding coappearing after allogeneic stem cell transplantation

Journal of Immunology

Volumn 199, Issue 2, 2017, Pages 792-805

  Ogonek, Justyna ^a   Verma, Kriti ^a   Schultze Florey, Christian ^a   Varanasi, Pavankumar ^a,b   Luther, Susanne ^a   Schweier, Patrick ^a   Kuhnau, Wolfgang ^a   Göhring, Gudrun ^a   Dammann, Elke ^a   Stadler, Michael ^a   Ganser, Arnold ^a   Koehl, Ulrike ^a   Koenecke, Christian ^a   Weissinger, Eva M ^a,b   Hambach, Lothar ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Center for Experimental and Clinical Infection Research   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD45RA ANTIGEN; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; T LYMPHOCYTE RECEPTOR; TETRAMER; CCR7 PROTEIN, HUMAN; CD3 ANTIGEN; CD45 ANTIGEN; HLA ANTIGEN;

ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BINDING KINETICS; CD8+ T LYMPHOCYTE; CELL ISOLATION; CELLULAR DISTRIBUTION; CHIMERA; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOMEGALOVIRUS; CYTOTOXICITY ASSAY; DOWN REGULATION; FEMALE; HUMAN; INFECTION RISK; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; T LYMPHOCYTE; VIRUS REACTIVATION; ADOLESCENT; ALLOTRANSPLANTATION; CELL PROLIFERATION; CHEMISTRY; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; DEFICIENCY; DONOR; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; KINETICS; METABOLISM; SECRETION (PROCESS); STEM CELL TRANSPLANTATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD3; ANTIGENS, CD45; CELL PROLIFERATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; INTERFERON-GAMMA; KINETICS; MALE; MIDDLE AGED; RECEPTORS, CCR7; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES, CYTOTOXIC; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 85023209971     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1601992     Document Type: Article

References (65)

1. Eid, A. J., S. J. Bakri, S. Kijpittayarit, and R. R. Razonable. 2008. Clinical features and outcomes of cytomegalovirus retinitis after transplantation. Transpl. Infect. Dis. 10: 13-18.
2. Mori, T., S. Mori, Y. Kanda, K. Yakushiji, S. Mineishi, Y. Takaue, H. Gondo, M. Harada, H. Sakamaki, T. Yajima, et al. 2004. Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 33: 431-434.
3. Ljungman, P., M. Hakki, and M. Boeckh. 2011. Cytomegalovirus in hematopoietic stem cell transplant recipients. Hematol. Oncol. Clin. North Am. 25: 151-169.
4. Hakki, M., S. R. Riddell, J. Storek, R. A. Carter, T. Stevens-Ayers, P. Sudour, K. White, L. Corey, and M. Boeckh. 2003. Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation. Blood 102: 3060-3067.
5. Gratama, J. W., J. W. J. van Esser, C. H. J. Lamers, C. Tournay, B. Löwenberg, R. L. H. Bolhuis, and J. J. Cornelissen. 2001. Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood 98: 1358-1364.
6. Gratama, J. W., M. Boeckh, R. Nakamura, J. J. Cornelissen, R. A. Brooimans, J. A. Zaia, S. J. Forman, K. Gaal, K. R. Bray, G. H. Gasior, et al. 2010. Immune monitoring with iTAg MHC tetramers for prediction of recurrent or persistent cytomegalovirus infection or disease in allogeneic hematopoietic stem cell transplant recipients: a prospective multicenter study. Blood 116: 1655-1662.
7. Cwynarski, K., J. Ainsworth, M. Cobbold, S. Wagner, P. Mahendra, J. Apperley, J. Goldman, C. Craddock, and P. A. H. Moss. 2001. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. Blood 97: 1232-1240.
8. Borchers, S., M. Bremm, T. Lehrnbecher, E. Dammann, B. Pabst, B. Wölk, R. Esser, M. Yildiz, M. Eder, M. Stadler, et al. 2012. Sequential anticytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation. [Published erratum appears in 2013 PLoS One 8. DOI:10.1371/annotation/43e9b84c-fbe3-4b39-88c8-1cde34b0afea.] PLoS One 7: e50248.
9. Özdemir, E., L. S. St John, G. Gillespie, S. Rowland-Jones, R. E. Champlin, J. J. Molldrem, and K. V. Komanduri. 2002. Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells. Blood 100: 3690-3697.
10. Vieira Braga, F. A., K. M. L. Hertoghs, R. A. W. van Lier, and K. P. J. M. van Gisbergen. 2015. Molecular characterization of HCMV-specific immune responses: parallels between CD8(+) T cells, CD4(+) T cells, and NK cells. Eur. J. Immunol. 45: 2433-2445.
11. Rufer, N., A. Zippelius, P. Batard, M. J. Pittet, I. Kurth, P. Corthesy, J.-C. Cerottini, S. Leyvraz, E. Roosnek, M. Nabholz, and P. Romero. 2003. Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions. Blood 102: 1779-1787.
12. Appay, V., R. A. W. van Lier, F. Sallusto, and M. Roederer. 2008. Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 73: 975-983.
13. Moins-Teisserenc, H., M. Busson, C. Scieux, V. Bajzik, J.-M. Cayuela, E. Clave, R. P. de Latour, F. Agbalika, P. Ribaud, M. Robin, et al. 2008. Patterns of cytomegalovirus reactivation are associated with distinct evolutive profiles of immune reconstitution after allogeneic hematopoietic stem cell transplantation. J. Infect. Dis. 198: 818-826.
14. Kato, T., T. Nishida, Y. Ito, M. Murase, M. Murata, and T. Naoe. 2014. Correlations of programmed death 1 expression and serum IL-6 level with exhaustion of cytomegalovirus-specific T cells after allogeneic hematopoietic stem cell transplantation. Cell. Immunol. 288: 53-59.
15. Scheinberg, P., J. J. Melenhorst, J. M. Brenchley, B. J. Hill, N. F. Hensel, P. K. Chattopadhyay, M. Roederer, L. J. Picker, D. A. Price, A. J. Barrett, and D. C. Douek. 2009. The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor. Blood 114: 5071-5080.
16. Gillespie, G., T. Mutis, E. Schrama, J. Kamp, B. Esendam, J. F. Falkenburg, E. Goulmy, and P. Moss. 2000. HLA class I-minor histocompatibility antigen tetramers select cytotoxic T cells with high avidity to the natural ligand. Hematol. J. 1: 403-410.
17. Alexander-Miller, M. A., G. R. Leggatt, A. Sarin, and J. A. Berzofsky. 1996. Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL. J. Exp. Med. 184: 485-492.
18. Dalla Santa, S., A. Merlo, S. Bobisse, E. Ronconi, D. Boldrin, G. Milan, V. Barbieri, O. Marin, A. Facchinetti, G. Biasi, et al. 2014. Functional aviditydriven activation-induced cell death shapes CTL immunodominance. J. Immunol. 193: 4704-4711.
19. Price, D. A., J. M. Brenchley, L. E. Ruff, M. R. Betts, B. J. Hill, M. Roederer, R. A. Koup, S. A. Migueles, E. Gostick, L. Wooldridge, et al. 2005. Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses. J. Exp. Med. 202: 1349-1361.
20. Conrad, J. A., R. K. Ramalingam, R. M. Smith, L. Barnett, S. L. Lorey, J. Wei, B. C. Simons, S. Sadagopal, D. Meyer-Olson, and S. A. Kalams. 2011. Dominant clonotypes within HIV-specific T cell responses are PD-1(hi) and CD127(low) and display reduced variant cross-reactivity. J. Immunol. 186: 6871-6885.
21. Harari, A., C. Cellerai, F. Bellutti Enders, J. Köstler, L. Codarri, G. Tapia, O. Boyman, E. Castro, S. Gaudieri, I. James, et al. 2007. Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype. Proc. Natl. Acad. Sci. USA 104: 16233-16238.
22. Griffiths, S. J., N. E. Riddell, J. Masters, V. Libri, S. M. Henson, A. Wertheimer, D. Wallace, S. Sims, L. Rivino, A. Larbi, et al. 2013. Age associated increase of low avidity CMV-specific CD8(+) T cells that re-express CD45RA. J. Immunol. 190: 5363-5372.
23. Cai, J., J. Lee, E. Jankowska-Gan, R. Derks, J. Pool, T. Mutis, E. Goulmy, and W. J. Burlingham. 2004. Minor H antigen HA-1-specific regulator and effector CD8+ T cells, and HA-1 microchimerism, in allograft tolerance. J. Exp. Med. 199: 1017-1023.
24. Bodinier, M., M. A. Peyrat, C. Tournay, F. Davodeau, F. Romagne, M. Bonneville, and F. Lang. 2000. Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding. Nat. Med. 6: 707-710.
25. Giest, S., S. Grace, A. C. Senegaglia, R. Pasquini, R. M. Gonzalo-Daganzo, M. N. Fernandez, S. Mackinnon, J. A. Madrigal, and P. J. Travers. 2010. Cytomegalovirus-specific CD8(+) T cells targeting different HLA/peptide combinations correlate with protection but at different threshold frequencies. Br. J. Haematol. 148: 311-322.
26. Glucksberg, H., R. Storb, A. Fefer, C. D. Buckner, P. E. Neiman, R. A. Clift, K. G. Lerner, and E. D. Thomas. 1974. Clinical manifestations of graft-versushost disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18: 295-304.
27. van der Bij, W., R. Torensma, W. J. van Son, J. Anema, J. Schirm, A. M. Tegzess, and T. H. The. 1988. Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes. J. Med. Virol. 25: 179-188.
28. Borchers, S., S. Luther, U. Lips, N. Hahn, J. Kontsendorn, M. Stadler, S. Buchholz, H. Diedrich, M. Eder, U. Koehl, et al. 2011. Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation. Transpl. Infect. Dis. 13: 222-236.
29. O'Callaghan, N. J., and M. Fenech. 2011. A quantitative PCR method for measuring absolute telomere length. Biol. Proced. Online 13: 3.
30. Wang, F., X. Pan, K. Kalmbach, M. L. Seth-Smith, X. Ye, D. M. Antumes, Y. Yin, L. Liu, D. L. Keefe, and S. M. Weissman. 2013. Robust measurement of telomere length in single cells. Proc. Natl. Acad. Sci. USA 110: E1906-E1912.
31. Verma, K., J. Ogonek, P. R. Varanasi, S. Luther, I. Bunting, K. Thomay, Y. L. Behrens, E. Mischak-Weissinger, and L. Hambach. 2017. Human CD8+ CD57-TEMRA cells: too young to be called "old". PLoS One 12: e0177405.
32. Borchers, S., E. M. Weissinger, B. Pabst, T. Ganzenmueller, E. Dammann, S. Luther, H. Diedrich, A. Ganser, and M. Stadler. 2013. Expansion of recipientderived antiviral T cells may influence donor chimerism after allogeneic stem cell transplantation. Transpl. Infect. Dis. 15: 627-633.
33. Mattis, A. E., G. Bernhardt, M. Lipp, and R. Förster. 1997. Analyzing cytotoxic T lymphocyte activity: a simple and reliable flow cytometry-based assay. J. Immunol. Methods 204: 135-142.
34. Hambach, L., K.-W. Ling, J. Pool, Z. Aghai, E. Blokland, H. J. Tanke, J. A. Bruijn, H. Halfwerk, H. van Boven, B. Wieles, and E. Goulmy. 2009. Hypomethylating drugs convert HA-1-negative solid tumors into targets for stem cell-based immunotherapy. Blood 113: 2715-2722.
35. van Heijst, J. W. J., I. Ceberio, L. B. Lipuma, D. W. Samilo, G. D. Wasilewski, A. M. R. Gonzales, J. L. Nieves, M. R. M. van den Brink, M. A. Perales, and E. G. Pamer. 2013. Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation. Nat. Med. 19: 372-377.
36. Ravens, S., C. Schultze-Florey, S. Raha, I. Sandrock, M. Drenker, L. Oberdörfer, A. Reinhardt, I. Ravens, M. Beck, R. Geffers, et al. 2017. Human gd T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection. Nat. Immunol. 18: 393-401.
37. Peggs, K., S. Verfuerth, A. Pizzey, J. Ainsworth, P. Moss, and S. Mackinnon. 2002. Characterization of human cytomegalovirus peptide-specific CD8(+) Tcell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells. Blood 99: 213-223.
38. + and CD8+ regulatory T cells induced by human herpesvirus 6 infection. J. Virol. 88: 1011-1024.
39. van Halteren, A. G. S., E. Jankowska-Gan, A. Joosten, E. Blokland, J. Pool, A. Brand, W. J. Burlingham, and E. Goulmy. 2009. Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members. Blood 114: 2263-2272.
40. Avivi, I., D. Stroopinsky, J. M. Rowe, and T. Katz. 2013. A subset of CD8+ T cells acquiring selective suppressive properties may play a role in GvHD management. Transpl. Immunol. 28: 57-61.
41. Wooldridge, L., A. Lissina, D. K. Cole, H. A. van den Berg, D. A. Price, and A. K. Sewell. 2009. Tricks with tetramers: how to get the most from multimeric peptide-MHC. Immunology 126: 147-164.
42. Laugel, B., H. A. van den Berg, E. Gostick, D. K. Cole, L. Wooldridge, J. Boulter, A. Milicic, D. A. Price, and A. K. Sewell. 2007. Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties. J. Biol. Chem. 282: 23799-23810.
43. Lissina, A., K. Ladell, A. Skowera, M. Clement, E. Edwards, R. Seggewiss, H. A. van den Berg, E. Gostick, K. Gallagher, E. Jones, et al. 2009. Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers. J. Immunol. Methods 340: 11-24.
44. Kerry, S. E., J. Buslepp, L. A. Cramer, R. Maile, L. L. Hensley, A. I. Nielsen, P. Kavathas, B. J. Vilen, E. J. Collins, and J. A. Frelinger. 2003. Interplay between TCR affinity and necessity of coreceptor ligation: high-affinity peptide-MHC/TCR interaction overcomes lack of CD8 engagement. J. Immunol. 171: 4493-4503.
45. Ohnishi, M., T. Sakurai, Y. Heike, R. Yamazaki, Y. Kanda, Y. Takaue, H. Mizoguchi, and Y. Kawakami. 2005. Evaluation of cytomegalovirus-specific T-cell reconstitution in patients after various allogeneic haematopoietic stem cell transplantation using interferon-g-enzyme-linked immunospot and human leucocyte antigen tetramer assays with an immunodominant T-cell epitope. Br. J. Haematol. 131: 472-479.
46. Purbhoo, M. A., J. M. Boulter, D. A. Price, A.-L. Vuidepot, C. S. Hourigan, P. R. Dunbar, K. Olson, S. J. Dawson, R. E. Phillips, B. K. Jakobsen, et al. 2001. The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor z chain. J. Biol. Chem. 276: 32786-32792.
47. Cole, D. K., N. J. Pumphrey, J. M. Boulter, M. Sami, J. I. Bell, E. Gostick, D. A. Price, G. F. Gao, A. K. Sewell, and B. K. Jakobsen. 2007. Human TCR-binding affinity is governed by MHC class restriction. J. Immunol. 178: 5727-5734.
48. Reusser, P., R. Attenhofer, H. Hebart, C. Helg, B. Chapuis, and H. Einsele. 1997. Cytomegalovirus-specific T-cell immunity in recipients of autologous peripheral blood stem cell or bone marrow transplants. Blood 89: 3873-3879.
49. Sellar, R. S., F. A. Vargas, J. Y. Henry, S. Verfuerth, S. Charrot, B. Beaton, R. Chakraverty, S. A. Quezada, S. Mackinnon, K. J. Thomson, and K. S. Peggs. 2015. CMV promotes recipient T-cell immunity following reduced-intensity Tcell-depleted HSCT, significantly modulating chimerism status. Blood 125: 731-739.
50. Chalandon, Y., S. Degermann, J. Villard, L. Arlettaz, L. Kaiser, S. Vischer, S. Walter, M. H. M. Heemskerk, R. A. W. van Lier, C. Helg, et al. 2006. Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications. Blood 107: 389-396.
51. Frentsch, M., R. Stark, N. Matzmohr, S. Meier, S. Durlanik, A. R. Schulz, U. Stervbo, K. Jurchott, F. Gebhardt, G. Heine, et al. 2013. CD40L expression permits CD8+ T cells to execute immunologic helper functions. Blood 122: 405-412.
52. Drake III, D. R., R. M. Ream, C. W. Lawrence, and T. J. Braciale. 2005. Transient loss of MHC class I tetramer binding after CD8+ T cell activation reflects altered T cell effector function. J. Immunol. 175: 1507-1515.
53. Kao, C., M. A. Daniels, and S. C. Jameson. 2005. Loss of CD8 and TCR binding to class I MHC ligands following T cell activation. Int. Immunol. 17: 1607-1617.
54. Burlingham, W. J., and E. Goulmy. 2008. Human CD8+ T-regulatory cells with low-avidity T-cell receptor specific for minor histocompatibility antigens. Hum. Immunol. 69: 728-731.
55. Monteiro, J., F. Batliwalla, H. Ostrer, and P. K. Gregersen. 1996. Shortened telomeres in clonally expanded CD28-CD8+ T cells imply a replicative history that is distinct from their CD28+CD8+ counterparts. J. Immunol. 156: 3587-3590.
56. Focosi, D., M. Bestagno, O. Burrone, and M. Petrini. 2010. CD57+ T lymphocytes and functional immune deficiency. J. Leukoc. Biol. 87: 107-116.
57. Golden-Mason, L., B. Palmer, J. Klarquist, J. A. Mengshol, N. Castelblanco, and H. R. Rosen. 2007. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction. J. Virol. 81: 9249-9258.
58. Lindsey, W. B., M. W. Lowdell, G. E. Marti, F. Abbasi, V. Zenger, K. M. King, and L. S. Lamb, Jr. 2007. CD69 expression as an index of T-cell function: assay standardization, validation and use in monitoring immune recovery. Cytotherapy 9: 123-132.
59. Lim, D. G., K. Bieganowska Bourcier, G. J. Freeman, and D. A. Hafler. 2000. Examination of CD8+ T cell function in humans using MHC class I tetramers: similar cytotoxicity but variable proliferation and cytokine production among different clonal CD8+ T cells specific to a single viral epitope. J. Immunol. 165: 6214-6220.
60. Horton, H., N. Russell, E. Moore, I. Frank, R. Baydo, C. Havenar-Daughton, D. Lee, M. Deers, M. Hudgens, K. Weinhold, and M. J. McElrath. 2004. Correlation between interferon-g secretion and cytotoxicity, in virus-specific memory T cells. J. Infect. Dis. 190: 1692-1696.
61. Cellerai, C., M. Perreau, V. Rozot, F. Bellutti Enders, G. Pantaleo, and A. Harari. 2010. Proliferation capacity and cytotoxic activity are mediated by functionally and phenotypically distinct virus-specific CD8 T cells defined by interleukin-7Ra (CD127) and perforin expression. J. Virol. 84: 3868-3878.
62. Giest, S., A. McWhinnie, M.-P. Lefranc, A.-M. Little, S. Grace, S. Mackinnon, J. A. Madrigal, and P. J. Travers. 2012. Cytomegalovirus-specific CD8+ T cells targeting different peptide/HLA combinations demonstrate varying T-cell receptor diversity. Immunology 135: 27-39.
63. Link, C. S., A. Eugster, F. Heidenreich, E. Rucker-Braun, M. Schmiedgen, U. Oelschlägel, D. Kuhn, S. Dietz, Y. Fuchs, A. Dahl, et al. 2016. Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8(+) T cell receptor alpha repertoire following allogeneic transplantation. Clin. Exp. Immunol. 184: 389-402.
64. Kedl, R. M., J. W. Kappler, and P. Marrack. 2003. Epitope dominance, competition and T cell affinity maturation. Curr. Opin. Immunol. 15: 120-127.
65. Iancu, E. M., P. Corthesy, P. Baumgaertner, E. Devevre, V. Voelter, P. Romero, D. E. Speiser, and N. Rufer. 2009. Clonotype selection and composition of human CD8 T cells specific for persistent herpes viruses varies with differentiation but is stable over time. J. Immunol. 183: 319-331.